Denosumab Discontinuation - Clinical Experience

被引：0
|
作者：
Laursen, Natasha [1 ]
Solling, Anne Sophie [1 ]
Harslof, Torben [1 ]
Langdahl, Bente L. [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Endocrinol, Aarhus, Denmark
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SUN-LB 58
引用
收藏
页码：359 / 359
页数：1
相关论文
共 50 条
  • [41] Denosumab discontinuation: COVID-19 pandemic and beyond
    Minisola, Salvatore
    JBMR PLUS, 2024, 8 (07)
  • [42] Hypercalcemia following discontinuation of denosumab therapy: A systematic review
    Horiuchi, Keisuke
    Kobayashi, Eisuke
    Mizuno, Tsukasa
    Susa, Michiro
    Chiba, Kazuhiro
    BONE REPORTS, 2021, 15
  • [43] PERSISTENCE AND REASONS FOR DISCONTINUATION OF DENOSUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Mizuki, S.
    Kai, T.
    Mishima, K.
    Ikeuchi, H.
    Oryoji, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1751 - 1751
  • [44] Risk factors for denosumab discontinuation in patients with postmenopausal osteoporosis
    Hattori, Kyosuke
    Takahashi, Nobunori
    Kojima, Toshihisa
    Imagama, Shiro
    MODERN RHEUMATOLOGY, 2023, 33 (04) : 843 - 850
  • [45] Underestimation of Vertebral Fractures After Denosumab Discontinuation Response
    Cummings, Steven R.
    Ferrari, Serge
    Brown, Jacques P.
    Wang, Andrea T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (03) : 548 - 548
  • [46] DenosumabRebound associated vertebral fractures secondary to denosumab discontinuation
    Reactions Weekly, 2024, 1998 (1) : 185 - 185
  • [47] Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report
    Kashii, Masafumi
    Ebina, Kosuke
    Kitaguchi, Kazuma
    Yoshikawa, Hideki
    BONE REPORTS, 2020, 13
  • [48] Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases Report
    Lamy, Olivier
    Gonzalez-Rodriguez, Elena
    Stoll, Delphine
    Hans, Didier
    Aubry-Rozier, Berengere
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (02): : 354 - 358
  • [49] CLINICAL FEATURES ASSOCIATED WITH FRAGILITY FRACTURE AFTER DISCONTINUATION OF TREATMENT WITH DENOSUMAB: A CASE-CONTROL STUDY
    Senabre-Gallego, J. M.
    Rosas, J.
    Pons, A.
    Santos Soler, G.
    Bernal, J. A.
    Garcia-Gomez, J. A.
    Cano, C.
    Lorente Betoret, M.
    Barber, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 186 - 186
  • [50] Gestione clinica della terapia con Denosumab: in chi, quando e come interromperlaManagement of denosumab discontinuation in clinical practice: in whom, when and how to stop
    Stella Pigni
    Gherardo Mazziotti
    L'Endocrinologo, 2023, 24 (1) : 34 - 42
12345